Evidence map›Paper›PMID 34554099›Full record

ArticleJMIR cancer2021

Analysis of Population Differences in Digital Conversations About Cancer Clinical Trials: Advanced Data Mining and Extraction Study.

Edith A Perez, Elizabeth M Jaffee, John Whyte, Cheryl A Boyce, John D Carpten, Guillermina Lozano, Raymond M Williams, Karen M Winkfield, David Bernstein, Sung Poblete

Open access · goldAbstract read
In one paragraph

Article in JMIR cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 1 country.

Edith A PerezDivision of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, United States.ORCID https://orcid.org/0000-0002-5037-6677
Elizabeth M JaffeeSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, United States.ORCID https://orcid.org/0000-0003-3841-6549
John WhyteWebMD, New York, NY, United States.ORCID https://orcid.org/0000-0002-0715-5158
Cheryl A BoyceOhio Commission on Minority Health, Columbus, OH, United States.
John D CarptenInstitute of Translational Genomics, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.ORCID https://orcid.org/0000-0002-6862-2821
Guillermina LozanoDepartment of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.ORCID https://orcid.org/0000-0001-8985-4886
Raymond M WilliamsDLA Piper, Philadelphia, PA, United States.ORCID https://orcid.org/0000-0002-1508-0897
Karen M WinkfieldMeharry-Vanderbilt Alliance, Vanderbilt University Medical Center, Nashville, TN, United States.ORCID https://orcid.org/0000-0002-4996-8093
David BernsteinStand Up To Cancer, Los Angeles, CA, United States.ORCID https://orcid.org/0000-0002-4564-8578
Sung PobleteStand Up To Cancer, Los Angeles, CA, United States.ORCID https://orcid.org/0000-0003-2008-5796
Pancreatic Cancer Action Network · USJohns Hopkins University · USMayo Clinic in Florida · USOffice of Minority Health · USThe University of Texas MD Anderson Cancer Center · USUniversity of Southern California · USVanderbilt University Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRacial and ethnic diversity in clinical trials for cancer treatment is essential for the development of treatments that are effective for all patients and for identifying potential differences in toxicity between different demographics. Mining of social media discussions about clinical trials has been used previously to identify patient barriers to enrollment in clinical trials; however, a comprehensive breakdown of sentiments and barriers by various racial and ethnic groups is lacking.

objectiveThe aim of this study is to use an innovative methodology to analyze web-based conversations about cancer clinical trials and to identify and compare conversation topics, barriers, and sentiments between different racial and ethnic populations.

methodsWe analyzed 372,283 web-based conversations about cancer clinical trials, of which 179,339 (48.17%) of the discussions had identifiable race information about the individual posting the conversations. Using sophisticated machine learning software and analyses, we were able to identify key sentiments and feelings, topics of interest, and barriers to clinical trials across racial groups. The stage of treatment could also be identified in many of the discussions, allowing for a unique insight into how the sentiments and challenges of patients change throughout the treatment process for each racial group.

resultsWe observed that only 4.01% (372,283/9,284,284) of cancer-related discussions referenced clinical trials. Within these discussions, topics of interest and identified clinical trial barriers discussed by all racial and ethnic groups throughout the treatment process included health care professional interactions, cost of care, fear, anxiety and lack of awareness, risks, treatment experiences, and the clinical trial enrollment process. Health care professional interactions, cost of care, and enrollment processes were notably discussed more frequently in minority populations. Other minor variations in the frequency of discussion topics between ethnic and racial groups throughout the treatment process were identified.

conclusionsThis study demonstrates the power of digital search technology in health care research. The results are also valuable for identifying the ideal content and timing for the delivery of clinical trial information and resources for different racial and ethnic groups.

Indexed as

cancerclinical trialsdata mininghealth care disparitieshealth communicationnatural language processingrace and ethnicitysocial mediatext extraction

Identifiers

PMID34554099
PMCPMC8498899
OpenAlexW3167654141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.